ELI LILLY & CO
LLYNYSE🏆 #12 by market capEarnings Oct 29 · PreUS Equity
$1,290.67▲ $9.10 (+0.71%)
After hours · at closeTrack LLY
Get earnings, price moves & breaking news on Telegram
24h▲ 0.7%
7d▲ 1.6%
14d▲ 6.6%
30d▲ 8.9%
ytd▲ 20.1%
1y▲ 57.1%
🏦Market Cap
$1.21T
Mega Cap
📈Revenue Growth (YoY)
49.6%
High Growth
📊Gross Margin
83.4%
High
💵FCF Margin
17.0%
Healthy
⚖️P/S Ratio
15.2x
Expensive
Otter Score
80
Strong
Trading Snapshot
- Day Range
- $1262.17 – $1298.95
- 52-Week Range
- $806.02 – $1,321.21
- Volume (shares)
- 87,741
- Avg Volume (shares)
- —
- Shares Outstanding
- 941.4M
- Next Earnings
- 2026-10-29
Fundamentals Snapshot
- Annual Revenue
- $65.18B
- Last Q Revenue
- $22.97B
- P/E Ratio
- 45.3
- P/S Ratio
- 15.2x
- EPS (TTM)
- $29.80
- Dividend Yield
- 0.48%
- Dilution (1yr)
- −0.6%
ELI LILLY & CO
LLYFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$65.2B▲ +44.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
83.0%▲ +2.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$29.7B▲ +74.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$9.0B▲ +138.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
898.0M▼ −0.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$35.3B▼ −$5.0B YoY
StockOtter · stockotter.spaceAbout ELI LILLY & CO
Pharma with leading GLP-1 franchise (Mounjaro, Zepbound).
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
80/100
Analyst Ratings
ⓘConsensus
Buy
36 analysts
Strong Buy11
Buy20
Hold4
Sell1
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.